GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in AUD. All numbers in thousands
Revenue6/30/20186/30/20176/30/20166/30/2015
Total Revenue189.254518.506824.5862,011.918
Cost of Revenue300.088492.417743.061,326.661
Gross Profit-110.83426.08981.526685.257
Operating Expenses
Research Development2,210.4982,366.3342,688.3332,851.665
Selling General and Administrative4,210.5825,655.1336,188.288,727.287
Non Recurring----
Others---300.548-1,027.151
Total Operating Expenses6,721.1688,513.8849,319.12511,878.462
Operating Income or Loss-6,531.914-7,995.378-8,494.539-9,866.544
Income from Continuing Operations
Total Other Income/Expenses Net1,068.042-408.44835.5741,056.374
Earnings Before Interest and Taxes-6,531.914-7,995.378-8,494.539-9,866.544
Interest Expense-28.843-31.995-28.889-264.694
Income Before Tax-5,463.872-8,403.826-8,458.965-8,810.17
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-5,463.872-8,403.826-8,458.965-8,810.17
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,463.872-8,403.826-8,458.965-8,810.17
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,463.872-8,403.826-8,458.965-8,810.17